acquired
Stage
About
Therox developed SuperSaturated Oxygen (SSO2) therapy that complements percutaneous coronary intervention to improve treatment outcomes for cardiovascular patients.
Explore Therox's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.